| 000 | 01799 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513140353.0 | ||
| 264 | 0 | _c19980324 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-199803000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrosgart, C L | |
| 245 | 0 | 0 |
_aA randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cFeb 1998 |
||
| 300 |
_a269-77 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xprevention & control |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCytomegalovirus |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xprevention & control |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanciclovir _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLouis, T A | |
| 700 | 1 | _aHillman, D W | |
| 700 | 1 | _aCraig, C P | |
| 700 | 1 | _aAlston, B | |
| 700 | 1 | _aFisher, E | |
| 700 | 1 | _aAbrams, D I | |
| 700 | 1 | _aLuskin-Hawk, R L | |
| 700 | 1 | _aSampson, J H | |
| 700 | 1 | _aWard, D J | |
| 700 | 1 | _aThompson, M A | |
| 700 | 1 | _aTorres, R A | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 12 _gno. 3 _gp. 269-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-199803000-00004 _zAvailable from publisher's website |
| 999 |
_c9485735 _d9485735 |
||